Abstract Background Direct oral anticoagulants (DOACs) have become preferable for the
management of thromboembolic events. Recent publications have however identified high …

Background For more than a decade, direct oral anticoagulants (DOACs) have been
approved in clinical practice for multiple indications such as stroke prevention in non …

Purpose This study aimed to estimate the prevalence, contributory factors, and severity of
medication errors associated with direct acting oral anticoagulants (DOACs). Methods A …

Abstract Background Direct oral anticoagulants (DOACs) are considered high‐risk
medications and pose a serious threat to patients if mismanaged. Furthermore, medication …

Stroke and venous thromboembolism continues to be a major cause of morbidity and
mortality worldwide. The use of anticoagulation therapy has proven effective in the …

Abstract Background Direct oral anticoagulants (DOACs) have revolutionised anticoagulant
pharmacotherapy. However, DOAC-related medication incidents are known to be common …

Abstract Recent analyses demonstrate roughly 16–24% of patients taking direct-acting oral
anticoagulants (DOACs) are prescribed an inappropriate dose, exposing patients to …

ABSTRACT Introduction Direct oral anticoagulants (DOACs) are considered high risk
medicines and are frequently associated with medication errors. The nature of incidents and …

Introduction: Anticoagulants are associated with significant harm when used in error, but
there are limited data on potential harm of inappropriate treatment with direct oral …

Direct oral anticoagulant drugs (DOACs) interfere with the coagulation process, thus
improving patient care for those who require anticoagulant treatment. This study presents a …